A recent study published in Therapeutic Advances in Endocrinology and Metabolism compares two approaches for managing diabetic foot with osteomyelitis: amputation versus circular external fixation (CEF). The research highlights a pressing issue in diabetes care, as Charcot foot—a severe complication involving infected ulcers—often leads to amputation, with five-year mortality rates reaching as high as 70%.
Key Findings
1. Quality of Life: Patients treated with CEF reported a significant improvement in quality of life, contrasting sharply with those who underwent amputation, where quality-of-life measures generally declined.
2. Survival Rates: The study found a notable difference in survival, with a 3-year survival rate of 90% for CEF-treated patients compared to 60.8% for those who had an amputation, underlining CEF’s potential advantage in mortality outcomes.
3. Costs: Interestingly, both treatment modalities presented similar total costs (approximately €222,864 for amputation and €224,438 for CEF). However, CEF showed better outcomes in several specific pre- and post-treatment expenses, suggesting nuanced financial benefits.
Implications
These findings add weight to the potential of external fixation as an alternative to amputation for managing diabetic foot with osteomyelitis. With comparable costs but better quality of life and survival outcomes, CEF could be a pivotal approach for improving patient experiences and outcomes in diabetic foot care.
For further details, read the full study here .
Leave a Reply